TY - JOUR T1 - Household secondary attack rate of COVID-19 by household size and index case characteristics JF - medRxiv DO - 10.1101/2021.02.23.21252287 SP - 2021.02.23.21252287 AU - Semra Tibebu AU - Kevin A. Brown AU - Nick Daneman AU - Lauren A. Paul AU - Sarah A. Buchan Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/25/2021.02.23.21252287.abstract N2 - In this population-wide study in Ontario, Canada, we investigated the household secondary attack rate (SAR) to understand its relationship to household size and index case characteristics. We identified all patients with confirmed COVID-19 between July 1 and November 30, 2020. Cases within households were matched based on reported residential address; households were grouped based on the number of household contacts. The majority of households (68.2%) had a SAR of 0%, while 3,442 (11.7%) households had a SAR ≥75%. Overall household SAR was 19.5% and was similar across household sizes, but varied across index case characteristics. Households where index cases had longer delays between symptom onset and test seeking, households with older index cases, households with symptomatic index cases, and larger households located in diverse neighborhoods, were associated with greater household SAR. Our findings present characteristics associated with greater household SARs and proposes immediate testing as a method to reduce household transmission and incidence of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by Public Health Ontario.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We obtained ethics approval from Public Health Ontario's Research Ethics Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors had full access to all data in the study and accept responsibility for the decision to submit for publication. ER -